Expert: FTC Clinical Data Requirements A Likely Challenge For Medtech Companies

Medtech Insight spoke to Sidley Austin LLP partner Jeff Senger about the challenges companies may face navigating the FTC’s updated health products guidance.

• Source: Shutterstock

The randomized clinical trial (RCT) requirements in the Federal Trade Commission’s updatedHealth Products Compliance Guidanceare going to be challenging for medical device companies, Sidley Austin LLP partner Jeff Senger told Medtech Insight.

All health-related claims need to be backed with high-quality RCTs under the new FTC guidance,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D